“We believe this investment not only further validates the potential of our technology platform, but also reinforces the therapeutic and market opportunity of our two lead clinical assets,” Founder and CEO R.A. Session II says.
R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]
Main Event's current CEO Chris Morris will be named CEO of Dave & Buster's. [Photo: Morris' LinekdIn profile]
WatchGuard develops mobile video cameras and evidence management software for law enforcement. [Photo courtesy of WatchGuard]